Abstract
As EHDS unlocks Europe’s health data and MDR raises the evidence bar across the device lifecycle, medtechs face a strategic choice: source real-world data they didn’t generate, or keep creating bespoke clinical evidence.
Either way, one question decides whether it holds up to a Notified Body – is the data fit for purpose, and who’s accountable for proving it? Join our roundtable to compare strategies for staying ahead of a regulatory target that keeps moving.Speakers
Frank Trautwein – Director Clinical Strategy,
Veeva MedTech
Abstract
Join us to discuss clinical readiness by exploring where agents deliver value today, and where they break. Learn how to successfully adopt AI by focusing on three key layers – a unified data foundation, supervision-first workflows, and audit-survivable governance. The insights will help you:
